🇺🇸 FDA
Patent

US 9175070

Neutralizing antibodies to HIV-1 and their use

granted A61KA61K39/42A61K45/06

Quick answer

US patent 9175070 (Neutralizing antibodies to HIV-1 and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K39/42, A61K45/06, A61P, A61P31/18